Injective INJ
Current Price
$3.10 +0.57%
$0.1000 Daily Range (3.23%)
$3.06$3.16
$51.46M Daily Volume
710 BTC
Vol/MktCap: 16.61%
Market Performance
0.08% Relative BTC Volume
The total volume of Injective is $51.46M over the past 24 hours, compared to $67.41B total Bitcoin volume.
Hourly Moving Average
8 SMA $3.09 +0.42%
13 SMA $3.09 +0.33%
21 SMA $3.11 -0.22%
55 SMA $3.06 +1.17%
144 SMA $3.06 +1.43%
Price Performance
+0.60% 1 Hour Change
$3.10 from $3.08
-2.98% 7 Day Change
-$0.0924 from $3.19
-3.21% 14 Day Change
-$0.0996 from $3.20
-15.85% 30 Day Change
-$0.4913 from $3.59
All Time High
March 14, 2024
$52.62 -94.12%
-$49.52 vs. now
24H Change
1.71M USD +0.56%
24 BTC
Volume and Supply
Total Supply: 100.00M INJ 
100.00M INJ Available100.00% circulating A lower circulating supply may increase over time, reducing scarcity and potentially causing a drop in price. A higher circulating supply is less susceptible to dilution, offering the potential for a more stable price long-term.
Relative Supply Ratio
5.00 x BTC Supply5:1 supply ratio
RSR reflects potential differences in tokenomics, such as inflation rates, utility, or burn mechanisms, which can impact long-term value and scarcity.
Relative Trade Volume
16.55M INJ
traded over past 24 hours
16.55% of circulating supply
A higher trade volume relative to market cap indicates strong market activity and liquidity, while a lower ratio may suggest reduced interest, lower liquidity, or potential price stagnation.
Conversion Tool
Injective AI Market Analysis
Injective (INJ) is currently priced at $3.08, reflecting a slight decline of 0.36% over the last 24 hours. The daily trading range remains narrow, with a high of $3.16 and a low of $3.06, indicating a period of consolidation.
Volume stands at 51,390,626, representing 16.69% of its market cap, which suggests moderate trading activity. The hourly moving averages reveal a bearish trend, with the 8 SMA and 13 SMA both showing negative momentum, while the longer-term SMAs (55 and 144) indicate a slight bullish sentiment.
The 1-hour RSI is at 41, signaling a potential oversold condition, but still within neutral territory. In contrast, the 7-day RSI is at 49, reflecting a balanced market sentiment but indicating a downward trend with a 7-day price change of -3.61%.
Over the past 14 days, INJ has experienced a price decrease of 3.84%, and a more substantial decline of 16.39% over the last 30 days. This longer-term downtrend, coupled with the proximity to critical support levels, suggests caution among traders.
Injective's all-time high of $52.62, reached on March 14, 2024, provides a stark contrast to its current valuation, emphasizing a significant retracement. The market appears to be digesting previous gains, and the recent price behavior indicates potential for a short-term rebound.
Considering the technical indicators and the recent price action, I recommend a Hold rating for Injective (INJ). The current price level reflects a consolidation phase, and potential buyers may want to observe for a confirmation of upward movement before entering the market.
Volume stands at 51,390,626, representing 16.69% of its market cap, which suggests moderate trading activity. The hourly moving averages reveal a bearish trend, with the 8 SMA and 13 SMA both showing negative momentum, while the longer-term SMAs (55 and 144) indicate a slight bullish sentiment.
The 1-hour RSI is at 41, signaling a potential oversold condition, but still within neutral territory. In contrast, the 7-day RSI is at 49, reflecting a balanced market sentiment but indicating a downward trend with a 7-day price change of -3.61%.
Over the past 14 days, INJ has experienced a price decrease of 3.84%, and a more substantial decline of 16.39% over the last 30 days. This longer-term downtrend, coupled with the proximity to critical support levels, suggests caution among traders.
Injective's all-time high of $52.62, reached on March 14, 2024, provides a stark contrast to its current valuation, emphasizing a significant retracement. The market appears to be digesting previous gains, and the recent price behavior indicates potential for a short-term rebound.
Considering the technical indicators and the recent price action, I recommend a Hold rating for Injective (INJ). The current price level reflects a consolidation phase, and potential buyers may want to observe for a confirmation of upward movement before entering the market.
Updated 50 minutes ago.
Injective Relative Price at Market Cap of:
Injective TradingView Chart
In The News

Kraken Becomes First Crypto Firm To Gain Access To Federal Reserve’s Master Accounts – Report
Kraken, the US’s second-largest crypto exchange, has reportedly secured access to the Federal Reserve’s (Fed) core payment systems, marking a significant milestone as the first…

Binance coin price prediction 2026-2032: How high will BNB go?
Key takeaways: After notable changes in its executive team, Binance has shown resilience and prospects for recovery.

Kraken Gains Fed Access: Could Ripple Follow With Its Own Master Account?
Kraken’s latest regulatory milestone has fueled speculation across the crypto community about whether Ripple could be next in line.

Crypto platform aims to let retail investors buy IPO shares at the same price as Wall Street insiders
Most people only see IPOs after the price resets at the open.